A New Insight into Meloxicam: Assessment of Antioxidant and Anti-Glycating Activity in In Vitro Studies
Meloxicam is a non-steroidal anti-inflammatory drug, which has a preferential inhibitory effect to cyclooxyganase-2 (COX-2). Although the drug inhibits prostaglandin synthesis, the exact mechanism of meloxicam is still unknown. This is the first study to assess the effect of meloxicam on protein gly...
Main Authors: | Cezary Pawlukianiec, Małgorzata Ewa Gryciuk, Kacper Maksymilian Mil, Małgorzata Żendzian-Piotrowska, Anna Zalewska, Mateusz Maciejczyk |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-09-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/13/9/240 |
Similar Items
-
Phloroglucinol prevents albumin glycation as well as diminishes ROS production, glycooxidative damage, nitrosative stress and inflammation in hepatocytes treated with high glucose
by: Krzysztof Drygalski, et al.
Published: (2021-10-01) -
Salivary Gland Dysfunction in Patients with Chronic Heart Failure Is Aggravated by Nitrosative Stress, as Well as Oxidation and Glycation of Proteins
by: Anna Klimiuk, et al.
Published: (2021-01-01) -
High Protein Diet Induces Oxidative Stress in Rat Cerebral Cortex and Hypothalamus
by: Ewa Żebrowska, et al.
Published: (2019-03-01) -
Biomarkers of Glyco-Metabolic Control in Hemodialysis Patients: Glycated Hemoglobin vs. Glycated Albumin
by: Francesca Gabriela Martino, et al.
Published: (2021-07-01) -
Antioxidant and Antiglycation Properties of Seventeen Fruit Teas Obtained from One Manufacturer
by: Izabela Zieniewska, et al.
Published: (2020-07-01)